Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics DH consultation: Governance arrangements for controlled drugs The Department of Health (DH) is consulting on proposed changes to the governance arrangements for controlled drugs in England and Scotland, including the role and functions of […]
Latest articles
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Ketamine injection supply problems Pfizer UK has confirmed that there is a supply problem with ketamine (Ketalar) 10mg/mL and 100mg/mL injection. All orders for these products are now being re-directed to a Pfizer central […]
SHORTCUTS
Articles of interest in other scholarly journals Pain outcomes in patients with advanced breast cancer and bone metastases: Results from a randomized, double-blind study of denosumab and zoledronic acid. Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, Patrick DL, Clemons M, Tonkin K, Masuda N, Lipton A, de Boer […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates NICE final draft guidance for denosumab The UK National Institute for Health and Clinical Excellence (NICE) has published final draft guidance on the use of denosumab for the treatment of bone metastases from solid tumours […]
SHORTCUTS
Articles of interest in other scholarly journals. Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? a qualitative study Miriam J Johnson, Laura Sheard, Anthony Maraveyas, Simon Noble, Hayley Prout, Ian Watt and Dawn Dowding Using think aloud exercises and interviews of oncologists, palliative physicians and general practitioners, […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates NPSA insulin passport deadline NHS organisations should ensure that by 31 August 2012 the following actions, outlined in the National Patient Safety Agency (NPSA) alert ‘The adult patient’s passport for safer use of insulin’ (NPSA/2011/PSA003), […]
Do ‘humorous’ references to murder and euthanasia reflect societal beliefs about palliative care?
A recent survey of palliative care doctors published in the Mayo Clinic Proceedings investigates the role that gallows humour plays in the relationships between palliative care physicians and their patients and colleagues. The online survey, developed by Lewis Cohen MD and colleagues from Tufts University School of Medicine, found that nearly three-quarters of doctors interviewed […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Olanzapine injection to be discontinued in UK Olanzapine injection, powder for reconstitution 5mg/mL, 10mg vial (Zyprexa; Lilly), is to be discontinued in theUK31st August 2012, for sales volume reasons. There is no generic or alternative […]
SHORTCUTS
Articles of interest in other scholarly journals. Meta-analysis: non-steroidal anti-inflammatory drugs in biliary colic. Colli A, Conte D, Valle SD, Sciola V, Fraquelli M. This systematic review with meta-analysis assessed the analgesic benefits and reduction of complications, as well as the potential harms from randomised clinical trials (RCTs) evaluating non-steroid anti-inflammatory drugs (NSAIDs) in […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics FDA approve REMS for m/r opioids USFood and Drug administration (FDA) has approved a Risk Evaluation and Mitigation Strategy (REMS) program for all modified-release (m/r) opioids. Key components include prescriber training, updated patient information guides […]